FSD Pharma Inc.
FSD Pharma Inc. (HUGE) Revenue
Annual & quarterly revenue history · segment & region breakdown
HUGE · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsFSD Pharma Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
Compare revenue vs peers
Drug Manufacturers - Specialty & GenericCompare HUGE revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income FSD Pharma Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
FSD Pharma Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from FSD Pharma Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
HUGE revenue · 4 questionsHUGE's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · FSD Pharma Inc. SEC filings · GAAP · FSD Pharma Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026